CA4 and neoplasm: proposed a poly(l‐glutamic acid)‐CA4 conjugate(PLG‐CA4) prodrug nanomedicine which resulted in a 74% tumor suppression rate while commercial CA4 phosphate only showed 24%, attributing to the PLG‐CA4 being largely spread around the tumor vessels (Figure 15A).[225]